by lythamcorp | Nov 14, 2024 | ChromaDex News, Consumer
The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement LOS ANGELES – ChromaDex Corp. (NASDAQ: CDXC), the global authority on...
by lythamcorp | Nov 14, 2024 | Healthcare, Trinity Biotech, Trinity Biotech News
Conference Call Scheduled for Friday, November 15, 2024 at 10:00 AM ETDUBLIN, Ireland, Nov. 14, 2024 — Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human...
by lythamcorp | Nov 14, 2024 | Industrials, LiqTech, LiqTech News
BALLERUP, Denmark, Nov. 14, 2024 — LiqTech International, Inc. (Nasdaq: LIQT) (“LiqTech”), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the third...
by lythamcorp | Nov 13, 2024 | Healthcare, Shuttle Pharmaceuticals
GAITHERSBURG, Md., Nov. 13, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer...
by lythamcorp | Nov 13, 2024 | Aytu BioPharma, Healthcare
Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue up 54% sequentially$20.1 million cash balance at September 30, 2024Organizational changes and operating optimization plan...